<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is characterized by the presence of venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, recurrent fetal losses and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, associated with the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) </plain></SENT>
<SENT sid="1" pm="."><plain>This syndrome may be "primary" or may be associated with other diseases, mainly <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="2" pm="."><plain>However, some patients present the clinical picture of this syndrome but without evidence of aPL in their serum </plain></SENT>
<SENT sid="3" pm="."><plain>The term "seronegative" APS has been proposed to categorize these patients </plain></SENT>
<SENT sid="4" pm="."><plain>Here with we present two patients with seronegativity for aPL at the time of a thrombotic event, but in whom these antibodies were detected 2 and 7 months later </plain></SENT>
</text></document>